Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial

Published:2016-09-21 Issue:11 Volume:31 Page:1649-1657
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Poewe Werner¹,Burbaud Pierre²³,Castelnovo Giovanni⁴,Jost Wolfgang H.⁵,Ceballos-Baumann Andres O.⁶,Banach Marta⁷,Potulska-Chromik Anna⁸,Ferreira Joaquim J.⁹,Bihari Katalin¹⁰,Ehler Edvard¹¹,Bares Martin¹²¹³¹⁴,Dzyak Lyudmyla A.¹⁵¹⁶,Belova Anna N.¹⁷,Pham Emmanuel¹⁸,Liu Wenzhong Jerry¹⁹,Picaut Philippe¹⁷

Affiliation:

1. Department of Neurology; Innsbruck Medical University/University Hospital; Innsbruck Austria

2. Department of Clinical Neurophysiology; CHU de Bordeaux; Bordeaux France

3. Institut des Maladies Neurodégénératives; Université de Bordeaux; Bordeaux France

4. Department of Neurology; University Hospital Caremeau; Nimes France

5. Department of Neurology; University of Freiburg; Freiburg Germany

6. Schön Klinik München Schwabing, Department of Neurology; Technische Universität München; München Germany

7. Department of Neurology; Jagiellonian University Medical College; Kraków Poland

8. Department of Neurology; Medical University of Warsaw; Warsaw Poland

9. Clinical Pharmacology Unit, Instituto de Medicina Molecular, Faculty of Medicine; University of Lisbon; Lisbon Portugal

10. National Institute of Clinical Neurosciences; Budapest Hungary

11. Department of Neurology; County Hospital Pardubice; Pardubice Czech Republic

12. 1st Department of Neurology, Faculty of Medicine; Masaryk University; Brno Czech Republic

13. St Anne's University Hospital; Brno Czech Republic

14. Department of Neurology, Medical School; University of Minnesota; Minneapolis Minnesota USA

15. Dnipropetrovsk State Medical Academy, Dnipropetrovsk Regional Clinical Hospital Mechnykov; Mechnykov Ukraine

16. Department of Neurology; Zhovtneva Ploshcha Ukraine

17. Research Institute of Traumatology and Orthopaedics; Nizhnyi Novgorod Russia

18. Ipsen Innovation; Les Ulis France

19. Ipsen Biopharmaceuticals Inc; Basking Ridge New Jersey USA

Funder

Ipsen

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference21 articles.

1. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population;Jankovic;Parkinsonism Relat Disord,2007

2. Effect of cervical dystonia on employment: a retrospective analysis of the ability of treatment to restore premorbid employment status;Molho;Mov Disord,2009

3. EFNS guidelines on diagnosis and treatment of primary dystonias;Albanese;Eur J Neurol,2011

4. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia;Marsh;BMC Neurol,2014

5. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia;Swope;Neurol Clin,2008

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review;Parkinsonism & Related Disorders;2024-08

2. Cervical muscular dystonia. Modern approaches to treatment;Perm Medical Journal;2024-07-19

3. Current use of neurotoxins for alleviating symptoms of cervical dystonia;Expert Review of Neurotherapeutics;2024-06-19

4. Botulinum toxin preparations: areas for improvement and issues of standardisation;Biological Products. Prevention, Diagnosis, Treatment;2023-07-03

5. Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based Review;Dystonia;2022-09-20